Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-08-19
1986-07-01
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 98, 514866, C07D22114, A61K 3147
Patent
active
045980810
ABSTRACT:
1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid having the following ructural formula ##STR1## A pharmaceutical composition for treating diabetes mellitus complications comprises an active agent and a pharmaceutical base material, wherein the active agent is a compound selected from the group consisting of 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, and the sodium and potassium salts thereof.
REFERENCES:
patent: 3821383 (1974-06-01), Sestanj
patent: 4118495 (1978-10-01), Lippman
Bianchi et al., Chem. Abs. 64, 19481(a) 1967.
Efimov Andrei S.
Efimova Elena K.
Gordienko Vadim M.
Kaminsky Leonid A.
Kirichek Lora M.
Berch Mark L.
Institut Organicheckoi Khimii
Nauchno-Issledovatelsky Institut Endokrinologii I Obmena Vesches
Nauchno-Issledovatelsky Institut Farmakologii I Toksikologii
LandOfFree
1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacolo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacolo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-dioxo-1H-benz(de)isoquinoline-2(3H) butyric acid, pharmacolo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1082723